Anlotinib combined with tislelizumab in the treatment of primary small cell neuroendocrine carcinoma of the prostate: a case report and literature review - Fei, Xin; Zheng, Zhong; Zhao, Zhen-ya; Ren, Da-wei; Wang, Su-ying; Ye, Shi-jie; Liang, Lin-chun; Li, Da; Jia, Xiao-long; Ma, Qi (Frontiers in Immunology, 2024)